Suppr超能文献

泛癌种中 HLA 基因表达与癌症预后和免疫治疗疗效的关联。

Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy.

机构信息

Department of Molecular and Systems Biology, Dartmouth College, Hanover, NH, USA.

Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

出版信息

Br J Cancer. 2021 Aug;125(3):422-432. doi: 10.1038/s41416-021-01400-2. Epub 2021 May 12.

Abstract

BACKGROUND

The function of major histocompatibility complex (MHC) molecules is to bind peptide fragments derived from genomic mutations or pathogens and display them on the cell surface for recognition by cognate T cells to initiate an immune response.

METHODS

In this study, we provide a comprehensive investigation of HLA gene expression in a pan-cancer manner involving 33 cancer types. We utilised gene expression data from several databases and immune checkpoint blockade-treated patient cohorts.

RESULTS

We show that MHC expression varies strongly among cancer types and is associated with several genomic and immunological features. While immune cell infiltration was generally higher in tumours with higher HLA gene expression, CD4+ T cells showed significantly different correlations among cancer types, separating them into two clusters. Furthermore, we show that increased HLA gene expression is associated with prolonged survival in the majority of cancer types. Lastly, HLA gene expression is associated with patient response to immune checkpoint blockade, which is especially prominent for HLA class II expression in tumour biopsies taken during treatment.

CONCLUSION

We show that HLA gene expression is an important feature of tumour biology that has significant impact on patient prognosis.

摘要

背景

主要组织相容性复合体(MHC)分子的功能是结合来自基因组突变或病原体的肽片段,并将其呈现在细胞表面,以便同源 T 细胞识别,从而引发免疫反应。

方法

本研究以泛癌的方式对 HLA 基因表达进行了全面研究,涉及 33 种癌症类型。我们利用了来自多个数据库和免疫检查点阻断治疗患者队列的基因表达数据。

结果

我们表明,MHC 表达在癌症类型之间差异很大,与多种基因组和免疫学特征相关。虽然免疫细胞浸润在 HLA 基因表达较高的肿瘤中通常更高,但 CD4+T 细胞在癌症类型之间表现出明显不同的相关性,将它们分为两个簇。此外,我们表明,HLA 基因表达的增加与大多数癌症类型的生存延长相关。最后,HLA 基因表达与患者对免疫检查点阻断的反应相关,这在治疗期间取自肿瘤活检的 HLA Ⅱ类表达中尤为明显。

结论

我们表明,HLA 基因表达是肿瘤生物学的一个重要特征,对患者预后有重大影响。

相似文献

1
Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy.
Br J Cancer. 2021 Aug;125(3):422-432. doi: 10.1038/s41416-021-01400-2. Epub 2021 May 12.
2
Cancer immune escape: MHC expression in primary tumours versus metastases.
Immunology. 2019 Dec;158(4):255-266. doi: 10.1111/imm.13114. Epub 2019 Oct 1.
4
Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion.
Mol Cancer Res. 2022 Aug 5;20(8):1272-1283. doi: 10.1158/1541-7786.MCR-21-0886.
5
HLA Class-I Expression and Cancer Immunotherapy.
Adv Exp Med Biol. 2019;1151:79-90. doi: 10.1007/978-3-030-17864-2_3.
8
Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung Cancer.
Clin Cancer Res. 2021 May 15;27(10):2837-2847. doi: 10.1158/1078-0432.CCR-20-3655. Epub 2021 Feb 18.
10
The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
Cancer Med. 2017 Jul;6(7):1614-1626. doi: 10.1002/cam4.1087. Epub 2017 Jun 10.

引用本文的文献

3
Neutrophil-Related Genes Predict Prognosis and Contribute to Immunosuppression in Acute Myeloid Leukemia.
Blood Lymphat Cancer. 2025 Aug 18;15:115-132. doi: 10.2147/BLCTT.S529074. eCollection 2025.
5
Novel Stemness-Associated Scores: Enhancing Predictions of Hepatocellular Carcinoma Prognosis and Tumor Immune Microenvironment.
Oncol Res. 2025 Jul 18;33(8):1991-2011. doi: 10.32604/or.2025.063993. eCollection 2025.

本文引用的文献

1
Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy.
Int J Clin Pract. 2020 Oct;74(10):e13585. doi: 10.1111/ijcp.13585. Epub 2020 Jul 7.
2
Immune crosstalk in cancer progression and metastatic spread: a complex conversation.
Nat Rev Immunol. 2020 Aug;20(8):483-497. doi: 10.1038/s41577-019-0271-z. Epub 2020 Feb 5.
3
Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing.
Front Immunol. 2020 Jan 10;10:3034. doi: 10.3389/fimmu.2019.03034. eCollection 2019.
5
MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Nature. 2019 Oct;574(7780):696-701. doi: 10.1038/s41586-019-1671-8. Epub 2019 Oct 23.
6
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
BMC Med Genomics. 2019 Jul 25;12(Suppl 6):107. doi: 10.1186/s12920-019-0544-1.
8
CD4 T cell help in cancer immunology and immunotherapy.
Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0.
9
Expression of HLA-DQA1 and HLA-DQB1 genes in B lymphocytes, monocytes and whole blood.
Int J Immunogenet. 2018 Jun;45(3):128-137. doi: 10.1111/iji.12367. Epub 2018 Apr 16.
10
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验